Bayer has taken some hits since it closed on its purchase of Monsanto in June 2018. Its stock price of $30.10 on June 8, 2018, has dipped to last Friday’s (October 4) $17.50 close. So far, Bayer is also 0 for 3 in glyphosate-cancer lawsuits. On the other hand, the cultural integration between the two firms is going well, says Liam Condon, president of Bayer Crop Science.
